Managing Complex Cases in Gastroenterology: A Curbside Guide

Preface
Contents
Contributors
Part I: General GI
	Chapter 1: Introduction to the General GI Section
	Chapter 2: Eosinophilic Esophagitis
	Chapter 3: Oropharyngeal Dysphagia
	Chapter 4: Achalasia
		Reference
	Chapter 5: Other Motility Disorders of the Esophagus and Achalasia
	Chapter 6: GERD
	Chapter 7: Refractory GERD
		Reference
	Chapter 8: Surgery for GERD
		Reference
	Chapter 9: Barrett’s Esophagus
		References
	Chapter 10: PEG Tubes
	Chapter 11: Autoimmune Metaplastic Atrophic Gastritis
	Chapter 12: Subepithelial Lesions and NETs
	Chapter 13: Viewpoints on Managing Common Clinical GI Disorders from a Practitioner with Over 50 Years of “Real-World” Experience
		Constipation
		Acute Diarrhea
		IBS-D
		Gastroparesis (We Are Presenting Several Scenarios Here for Comparison)
		GERD
		Microscopic Colitis
		Fecal Incontinence
		Diverticulitis
		References
	Chapter 14: Small Intestinal Bacterial Overgrowth
		Reference
	Chapter 15: Unusual Causes of Abdominal Pain and Controversies in Diagnosis
		References
	Chapter 16: Vascular Disorders of the Intestine
		References
	Chapter 17: Polypectomy
		Cold vs. Hot Snare for Flat Polyps
		Anticoagulation After Polypectomy
		EMR
		Pedunculated Polyp
		Post-Polypectomy Bleeding
		References
	Chapter 18: Rectal Incontinence
		References
	Chapter 19: Diverticulitis
		References
	Chapter 20: Pancreatic Cysts and Recurrent Pancreatitis
		“Idiopathic” Recurrent Pancreatitis
	Chapter 21: Chronic Pancreatitis
	Chapter 22: GI Oncology
	Chapter 23: Issues in Therapeutic Endoscopy
		Management of Refractory Benign Esophageal Stricture (RBES) Including Placement of Esophageal Stents
			Nutrition Needs
		Pancreatic Cancer
	Chapter 24: GI Pharmacology:
		Eosinophilic Esophagitis
		Helicobacter Pylori
		IBS-C, IBS-D, and Chronic Constipation
		Hepatitis C
		Hepatitis B
		Pancreatic Insufficiency
		Inflammatory Bowel Disease
		Autoimmune Hepatitis
Part II: IBD Compendium
	Chapter 25: Introduction to the Inflammatory Bowel Disease Compendium
	Chapter 26: Crohn’s Ileitis
		Reference
	Chapter 27: Ulcerative Colitis Refractory to Mesalamine
		References
	Chapter 28: Managing Crohn’s in a Patient with Prior MI
	Chapter 29: Managing Post-Op Crohn’s
	Chapter 30: Managing Pseudopolyps
		References
	Chapter 31: Ulcerative Colitis Refractory to Anti-TNF
		References
	Chapter 32: Acute Severe Ulcerative Colitis
	Chapter 33: Resistant/Refractory Proctitis
	Chapter 34: Vaccinations in Newly Diagnosed IBD
	Chapter 35: Ustekinumab vs Risankizumab in Crohn’s
		References
	Chapter 36: Use of Vedolizumab in UC
		Reference
	Chapter 37: Functional Diarrhea in IBD
	Chapter 38: When to Postpone Infusions
	Chapter 39: Musculoskeletal Complaints in a Patient on Anti-TNFs
	Chapter 40: Use of Immune Modulators in Patients Being Started on Anti-TNFs
	Chapter 41: Pyoderma Gangrenosum
	Chapter 42: UC in a Patient Who Failed Mesalamine and Anti-TNF
	Chapter 43: Patients with IBD Who Are Squeamish About Rectal Meds and Self-Injection
	Chapter 44: Colon Stricture in UC
	Chapter 45: Nonspecific Ileal Ulcers
	Chapter 46: Concern About Pneumocystis jirovecii
		References
	Chapter 47: Bloating in Crohn’s
	Chapter 48: Severe Diarrhea in a Patient on Chemotherapy
	Chapter 49: Microscopic Colitis
		Reference
	Chapter 50: Miscellaneous Questions About IBD
		References
Part III: Disorders of Gut–Brain Interaction
	Chapter 51: Introduction to Disorders of Gut-Brain Interaction
	Chapter 52: IBS-D
		References
	Chapter 53: IBS-C
		References
	Chapter 54: Functional Dyspepsia
		References
	Chapter 55: Bloating
		References
Part IV: Hepatology Compendium
	Chapter 56: Introduction to the Hepatology Compendium
	Chapter 57: Liver Enzyme Elevation-negative Work-up
	Chapter 58: Increased LFTs with Increased Iron
	Chapter 59: Increased LFTs with Low Ceruloplasmin
	Chapter 60: Normal Ceruloplasmin-Suspected Wilson’s
	Chapter 61: Increased LFTs-Alpha 1 Antitrypsin Deficiency
	Chapter 62: Suspected Gilbert’s
	Chapter 63: The Significance of AST > ALT
	Chapter 64: Marked Hyperbilirubinemia
	Chapter 65: Suspected NAFLD
		References
	Chapter 66: Treatment of NAFLD
	Chapter 67: Treatment of MASLD
		References
	Chapter 68: Alcohol and Liver Disease in Women
	Chapter 69: Alcoholic Hepatitis
	Chapter 70: Fatty Liver on Ultrasound with Normal LFTs
	Chapter 71: Evaluation for Liver Damage from Chronic ETOH Use
	Chapter 72: Ascites in a Patient Without Obvious Cirrhosis
	Chapter 73: Ascites in Cirrhosis of Unclear Etiology with Increased Mononuclear Cells
	Chapter 74: Low SAAG Ascites
	Chapter 75: Banding Esophageal Varices
	Chapter 76: Gastric Varices
	Chapter 77: Increased Ascites in a Stable Cirrhotic
		Reference
	Chapter 78: Complications Related to Managing Ascites
		References
	Chapter 79: Portal Vein Thrombosis in Cirrhosis
		References
	Chapter 80: PVT and Budd Chiari as a Complication of UC
	Chapter 81: HCC Management, Solitary Lesion in a Child’s A Cirrhosis
	Chapter 82: Management of Unresectable HCC in a Cirrhotic
	Chapter 83: HCC in NAFLD Without Cirrhosis
	Chapter 84: Managing Primary Biliary Cholangitis
		References
	Chapter 85: Advanced PBC
		References
	Chapter 86: Autoimmune Hepatitis
	Chapter 87: Autoimmune Hepatitis
		References
	Chapter 88: Primary Sclerosing Cholangitis
		References
	Chapter 89: PBC-AIH Overlap
		References
	Chapter 90: Immune-Tolerant Chronic HBV
		References
	Chapter 91: Immune-Active Chronic HBV
		References
	Chapter 92: HBV Treatment Discontinuation
		References
	Chapter 93: Differentiating Acute HBV from an Acute Exacerbation of Chronic HBV
		References
	Chapter 94: Acute HBV and Risk of HBV Reactivation
		References
	Chapter 95: Complicated HCV
	Chapter 96: Acute Liver Failure
	Chapter 97: Delayed Presentation of Tylenol Overdose
	Chapter 98: Candidates for Liver Transplant?
	Chapter 99: Frustrations with Waiting for a Transplant
	Chapter 100: Complications Posttransplant
Index